Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 12:00PM GMT
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good morning, everyone, and welcome to day 3 of the Morgan Stanley healthcare conference 2020. My name is David Lewis, medical device analyst at Morgan Stanley, and thanks for your -- for joining us bright and early, earlier for me than for you on the East Coast.

It's my pleasure to kind of kick off day 3 here with one of our large-cap companies, Boston Scientific. We have both their CEO, Michael Mahoney; as well as their CFO, Dan Brennan. Pleased to have you both this morning.

And with that, we're ready for action.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

So team, I thought we'd start off where I'd been starting off kind of all week and just talk about COVID-19 recovery, your thoughts and anything you're willing to share here post the quarter. How have month-on-month trends been here in the third quarter? Most of our companies have talked about kind of nice sequential month-on-month improvement. I just wondered if you could comment

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot